Unknown

Dataset Information

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.


ABSTRACT:

Background

Current strategies for cardiovascular disease (CVD) risk assessment among adults without known CVD are limited by suboptimal performance and a narrow focus on only atherosclerotic CVD (ASCVD). We hypothesized that a strategy combining promising biomarkers across multiple different testing modalities would improve global and atherosclerotic CVD risk assessment among individuals without known CVD.

Methods

We included participants from MESA (Multi-Ethnic Study of Atherosclerosis) (n=6621) and the Dallas Heart Study (n=2202) who were free from CVD and underwent measurement of left ventricular hypertrophy by ECG, coronary artery calcium, N-terminal pro B-type natriuretic peptide, high-sensitivity cardiac troponin T, and high-sensitivity C-reactive protein. Associations

SUBMITTER: de Lemos JA 

PROVIDER: S-EPMC5486874 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature